Hepatitis C virus infection reduces the lifespan of chimpanzees used in biomedical research.

Chimpanzees were used in hepatitis research for over three decades with the aim to identify and develop treatments for the virus, a leading cause of chronic liver disease in humans. We used a dataset of 120 chimpanzees housed at a single institution in Japan, 22 of whom became chronically infected with hepatitis C virus (HCV), to examine whether HCV infection results in a reduced lifespan as reported in humans. Survival analysis showed that HCV carriers experienced a higher mortality risk compared with non-carriers.

Comparative survival analyses among captive chimpanzees () in America and Japan.

Detailed, long-term datasets on the life histories of long-lived species such as great apes are necessary to understand their survival patterns but are relatively rare. Such information requires prolonged and consistent record-keeping over many generations, so for chimpanzees (), this equates to many decades of input. As life history variables can be altered by differences in environmental influences (whether natural or artificial), there is substantial value to being able to compare across populations.

Longevity and mortality of captive chimpanzees in Japan from 1921 to 2018.

Utilizing the Great Ape Information Network (GAIN), an open-access nationwide database containing the detailed life history information of all apes who have lived or currently reside in Japan, we present a robust chimpanzee life table by single year of age and sex including 821 individuals spanning nearly a century, current through March 11, 2019. While the demographic composition and status of captive chimpanzees in Japan has been previously reported, longevity and mortality statistics have not. We show that female and male survivorship do not differ significantly, and that a live-born chimpanzee in Japan can expect to live 28.